Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose co-transporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial
Sharing a 94% structural homology with native human GLP-1, Semaglutide is distinguished by three modifications: 1) amino-acid substitutions at position 8 (alanine to -aminoisobutyric acid or Aib) and position 34 (lysine to arginine), and acylation of the lysine in position 26 with a spacer consisting of two 8-amino-3,6-dioxaoctanoic acid (ADO) moieties, a glutamic acid moiety, and a C-18 fatty di-acid side chain (Lau et al., 2015)
Unlike pills or drinks, which might not work as well, our injections get right to the point where your body needs it most
Semaglutide is a GLP-1 medication that helps reduce appetite and supports weight loss under medical supervision.
They have been shown to be proteolytic and inhibit collagen formation in both cartilage and tendon
Bands of scar tissue developing between the abdomen and other organs can create abnormal connections (fistulas), resulting in pain, constipation, and intestinal blockage
